tirzepatide discontinuation Adults with obesity who discontinue semaglutide, achieve minimal weight loss Tirzepatide Enhances Weight Loss with

Our team provides ongoing support, education, and required lab testing to monitor your progress, titrate your dose safely, and ensure long-term maintenance of your metabolic health

It is not a suitable treatment for anyone diagnosed with or currently: Medullary Thyroid cancer Multiple endocrine neoplasias People with type 1 diabetes People with type 2 diabetes already taking a GLP-1 medication Pancreatitis Kidney disease Women who are pregnant or breastfeeding How Much Weight Can I Lose

Discard the vial and start with a fresh one

GobyMeds and most GLP-1 telehealth platforms are primarily designed for patients with obesity (BMI 30 or above) or those with at least one weight-related comorbidity at a BMI of 27 or above